GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » C-Rad AB (OSTO:CRAD B) » Definitions » Price-to-Owner-Earnings

C-Rad AB (OSTO:CRAD B) Price-to-Owner-Earnings : 118.11 (As of May. 28, 2024)


View and export this data going back to 2007. Start your Free Trial

What is C-Rad AB Price-to-Owner-Earnings?

As of today (2024-05-28), C-Rad AB's share price is kr43.70. C-Rad AB's Owner Earnings per Share (TTM) ended in Dec. 2023 was kr0.37. It's Price-to-Owner-Earnings for today is 118.11.


The historical rank and industry rank for C-Rad AB's Price-to-Owner-Earnings or its related term are showing as below:

OSTO:CRAD B' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 107.74   Med: 169.46   Max: 1448.65
Current: 113.99

During the past 13 years, the highest Price-to-Owner-Earnings of C-Rad AB was 1448.65. The lowest was 107.74. And the median was 169.46.


OSTO:CRAD B's Price-to-Owner-Earnings is ranked worse than
87.9% of 281 companies
in the Medical Devices & Instruments industry
Industry Median: 33.11 vs OSTO:CRAD B: 113.99

As of today (2024-05-28), C-Rad AB's share price is kr43.70. C-Rad AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr1.42. Therefore, C-Rad AB's PE Ratio for today is 30.77.

As of today (2024-05-28), C-Rad AB's share price is kr43.70. C-Rad AB's EPS without NRI for the trailing twelve months (TTM) ended in was kr1.42. Therefore, C-Rad AB's PE Ratio without NRI for today is 30.77.

During the past 13 years, C-Rad AB's highest PE Ratio without NRI was 191.90. The lowest was 26.62. And the median was 68.62.


C-Rad AB Price-to-Owner-Earnings Historical Data

The historical data trend for C-Rad AB's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Rad AB Price-to-Owner-Earnings Chart

C-Rad AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 186.97 152.05 1,505.41 - 114.67

C-Rad AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 114.67 -

Competitive Comparison of C-Rad AB's Price-to-Owner-Earnings

For the Medical Devices subindustry, C-Rad AB's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C-Rad AB's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, C-Rad AB's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where C-Rad AB's Price-to-Owner-Earnings falls into.



C-Rad AB Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

C-Rad AB's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=43.70/0.37
=118.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C-Rad AB  (OSTO:CRAD B) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


C-Rad AB Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of C-Rad AB's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


C-Rad AB (OSTO:CRAD B) Business Description

Traded in Other Exchanges
Address
Sjukhusvägen 12K, Uppsala, SWE, 753 09
C-Rad AB is a Sweden based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. The operating segments of the group are the Positioning segment which includes development and sales of products in the field of patient positioning during radiotherapy, including catalyst, sentinel, and HIT lasers; and the Imaging segment which includes the development of imaging devices and detectors for cancer treatments and dosimetry. It generates maximum revenue from the Positioning segment. The firm sells its products in Sweden and internationally.

C-Rad AB (OSTO:CRAD B) Headlines

No Headlines